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Abstract 
We present the first Corynebacterium associated therapy resistant granulomatous mastitis 
successfully treated with negative pressure wound therapy (NPWT). Our patient had received 
five different courses of antibiotic therapy, three surgical explorations before NPWT was 
introduced and resulted in healing. For a successful treatment, the use of targeted antibiotic 
therapy, steroid therapy and in case of progressive disease, wide excision is required. When 
this results in a large wound cavity, NPWT seems an effective and innovative option.  
Introduction 
Mastitis is often divided into lactational and non-lactational types. Common forms of non-
lactational mastitis include periductal mastitis and idiopathic granulomatous mastitis (IGM), 
although this latter is also more common in the peripartum period. Granulomatous mastitis 
(GM) is a rare form of inflammatory breast disease. Possible etiologies include mammary 
tuberculosis, other infections, autoimmune mechanisms and hypersensitivity reactions.  
 
Case Report 
A 32-year-old woman was first seen as outpatient with symptoms of right breast pain, 
erythema and swelling in June 2017. Mammography and core biopsy were performed and 
confirmed an inflammatory disease of the breast, with no granulomatous component, but 
many eosinophils, fewer neutrophils and a single histiocytic giant cell. The patient empirically 
received amoxicillin/clavulanic acid, followed by cefuroxime. After a temporary remission of 
a month, an abscess appeared in the breast. Abscess drainage was performed and a bacterial 
smear was taken. The microbiological analysis resulted in coagulase negative Staphylococci 
and Corynebacterium jeikeum, both sensitive to vancomycin, which the patient received for 
10 days. A second exploration was needed two months later, when two samples were taken 
for microbiological analysis, resulting in Staphylococcus epidermidis, so the patient received 
clindamycine. One month later, an abscess drainage and bacterial smear were repeated and 
specimens were excised for histology. The wound culture had Corynebacterium jeikeium, and 
the histology demonstrated GM with lipophilic microcysts. (Figure 1). 
In September 2017, the patient had a large wound surface without healing tendency due to 
prolonged infection, we considered debridement necessary. We decided to use negative 
pressure wound therapy (NPWT), which is useful in many different types and sizes of wounds 
[G1] megjegyzést írt: Akkor ebben a kettős tenyésztésben 
nem volt C. jeikeum? 
[2], and has been shown to have beneficial effects on wound healing. The Renasys-GO™ 
(Smith & Nephew Inc. Canada) system was used to apply NPWT after a rigorous debridement 
under general anesthesia (Figure 2 A/B). The initial continuous negative pressure of -90 
mmHg was increased to -120 mmHg. The foam dressing was changed every 3-5 days and a 
good granulation tissue formation was observed. After the first week of NPWT, the wound 
cavity decreased significantly in volume. The patient received linezolide as targeted 
antimicrobial therapy in addition to steroids. After 4 weeks, we completed the NPWT and a 
secondary closure of the wound was performed. The patient was cured 6 months after initial 
presentation. 
 
Discussion 
GM can present a clinical dilemma from diagnostic and therapeutic perspectives. There is 
increasing evidence of an association between Corynebacteria and a distinct pattern termed 
cystic neutropilic GM [1, 3, 4]. When none of the known etiologies can be proven, the disease 
is labelled as IGM. As the possibility of a Corynebacterium infection was often 
uninvestigated previously, there are cases erroneously classified as IGM. The distinct 
histological features of granulomatous inflammation with neutrophils in cystic spaces should 
prompt careful search for rare Gram-positive bacilli. Microbiological investigation for 
Corynebacteria should be instigated in the presence of these histological features. This may 
require special culture techniques [1, 3]. GM caused by a Corynebacterium is often resistant 
to common initial antibiotic therapy, and responds to tetracycline to which this strain was 
resistant. Sometimes, only targeted antibiotic treatment can be successful with additional 
surgical excision eliminating necrotic tissue favoring persistent infection. Extensive surgery is 
limited by esthetic problems. NPWT is nowadays widely used to treat acute, sub-acute and 
chronically infected wounds. The negative pressure generated by the closed system removes 
[G2] megjegyzést írt: Ugye jól értem, hogy azt akartad 
írni, hogy fél év alatt gyógyult meg? 
infectious debris and exudates, reduces edema, increases blood flow and neovascularization 
helping new granulation tissue development, and decreases bacterial colonization of wounds 
[5, 6].  To our knowledge, we present the first successful NPWT assisted treatment of 
Corynebacterium related, therapy resistant GM. In our case, more radical surgery could be 
avoided by combined antibiotic + steroid + innovative surgical therapies (NPWT).  
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 Legends 
Figure 1. A lobulocentric granuloma (arrows) featuring a Langhans-type giant cell 
(arrowhead). A few neutrophils are seen in the center of the granuloma. The asterixs label 
microcysts, which atypically do not contain neutrophils in this case, as described in cystic 
neutrophilic GM [1]. 
 
 Figure 2. A) Right breast after the excision of the granulomatous tissue, the cavity containing 
the tailored foam dressing of the NPWT kit; B) Foam dressing in the wound covered by the 
adhesive film and the suction port applied. 
 
